Biora Therapeutics Inc
NASDAQ:BIOR

Watchlist Manager
Biora Therapeutics Inc Logo
Biora Therapeutics Inc
NASDAQ:BIOR
Watchlist
Price: 0.22 USD Market Closed
Market Cap: $994.4k

During the last 3 months Biora Therapeutics Inc insiders have not bought any shares, and have not sold any shares.

The last transaction was made on Jul 5, 2022 by Sarna Surbhi , who sold 4.6k USD worth of BIOR shares.

Last Transactions:
Sarna Surbhi
$-18.3
Athyrium Opportunities Fund (B) Lp
$+80k
Ferrell Jeffrey
$+80k
Athyrium Opportunities Fund (B) Lp
$+3.5k
Ferrell Jeffrey
$+3.5k
Silvestry Damon
$+643.9
Silvestry Damon
$+1k
Alter Jeffrey D.
$+388
Athyrium Opportunities Fund (A) Lp
$+54k
Athyrium Capital Management, Lp
$+54k
Stylli Harry
$+2k
Cooper Matthew T
$+316.4
Cooper Matthew T
$+0
Stylli Harry
$+357.6
Athyrium Opportunities Fund (A) Lp
$+200k
Athyrium Capital Management, Lp
$+200k
Stylli Harry
$+2k
View All Transactions

During the last 3 months Biora Therapeutics Inc insiders have not bought any shares, and have not sold any shares.

The last transaction was made on Jul 5, 2022 by Sarna Surbhi , who sold 4.6k USD worth of BIOR shares.

Sold
0-3
months
0 USD
0
3-6
months
0 USD
0
6-9
months
0 USD
0
9-12
months
0 USD
0
Bought
0-3
months
No Insider Transactions
0
0 USD
3-6
months
No Insider Transactions
0
0 USD
6-9
months
No Insider Transactions
0
0 USD
9-12
months
No Insider Transactions
0
0 USD

Biora Therapeutics Inc
Insider Trading Chart

Biora Therapeutics Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Biora Therapeutics Inc
Last Insider Transactions

Global
Insiders Monitor

Biora Therapeutics Inc
Glance View

Market Cap
994.4k USD
Industry
Health Care

Progenity, Inc. engages in the provision of molecular and specialized diagnostic tests to clinicians. The company is headquartered in San Diego, California and currently employs 124 full-time employees. The company went IPO on 2020-06-19. The company delivers therapeutics in two areas: targeted delivery of therapeutics to the site of disease in the gastrointestinal tract and systemic delivery of biotherapeutics. Its research and development pipeline consists of Drug Delivery System (DDS), PGN-600, PGN-001, Oral Biotherapeutics Delivery System (OBDS), PGN-OB1 and PGN-OB2. PGN-600 is liquid formulation of tofacitinib delivered with the DDS for the treatment of ulcerative colitis. PGN-001 is an orally-delivered variant of adalimumab for the treatment of ulcerative colitis. PGN-OB1 is a combination product of a variant of adalimumab and the OBDS for the treatment of inflammatory conditions. PGN-OB2 is a combination product of a GLP-1 receptor agonist and the OBDS for the treatment of Type two diabetes. The OBDS platform is designed to enable delivery of liquid drug, reducing the need for reformulation.

BIOR Intrinsic Value
Not Available

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett